For citations:

Shubina K.M., Alieva A.M., Nikitin I.G. Sodium-glucose co-transporter type 2 inhibitors and non-alcoholic fatty liver disease. FOCUS. Endocrinology. 2024;5(3):45-54. (In Russ.) https://doi.org/10.62751/2713-0177-2024-5-3-06